Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
about
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritisClinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow upPTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.Biological function integrated prediction of severe radiographic progression in rheumatoid arthritis: a nested case control study.Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial.
P2860
Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Using estimated yearly progres ...... rials in rheumatoid arthritis.
@ast
Using estimated yearly progres ...... rials in rheumatoid arthritis.
@en
type
label
Using estimated yearly progres ...... rials in rheumatoid arthritis.
@ast
Using estimated yearly progres ...... rials in rheumatoid arthritis.
@en
prefLabel
Using estimated yearly progres ...... rials in rheumatoid arthritis.
@ast
Using estimated yearly progres ...... rials in rheumatoid arthritis.
@en
P2860
P1476
Using estimated yearly progres ...... trials in rheumatoid arthritis
@en
P2093
P2860
P304
P356
10.1136/ARD.61.SUPPL_2.II64
P407
P478
61 Suppl 2
P577
2002-11-01T00:00:00Z